| abstract |
A number of Janus kinase inhibitors have been proposed and, in particular, a compound of formula (I) or its pharmaceutically acceptable salts and a method for their preparation, as well as pharmaceutical compositions containing these compounds and the use of these compounds for the treatment of diseases associated with Janus kinase (JAK) |